Table 3.
Univariate survival analysis of prognostic factors of NSCLC (n = 42)
| Variables | n | Median survival (95% CI) (days) | P |
|---|---|---|---|
| Age (years) | |||
| <60 | 27 | 370.0 (301.3-438.7) | 0.665 |
| ≥ 60 | 15 | 333.0 (244.6-421.4) | |
| Stage | |||
| III | 23 | 416.0 (369.1-462.8) | 0.163 |
| IV | 19 | 327. 0 (298.7-355.3) | |
| T factor | |||
| T2-T3 | 17 | 431.0 (315.3-546.7) | 0.051 |
| T4 | 25 | 348.0 (248.3-447.6) | |
| N factor | |||
| N0-N1 | 21 | 394.0 (312.2-475.8) | 0.380 |
| N2-N3 | 21 | 348.0 (310.1-385.9) | |
| ECOG | |||
| 1 | 30 | 403.0 (327.9-478.0) | 0.130 |
| 2-3 | 12 | 333.0 (311.5-354.5) | |
| Histology | |||
| SCC | 31 | 367.0 (288.1-445.9) | 0.270 |
| ADC | 11 | 394.0 (324.8-463.1) | |
| Smoking habit | |||
| Smokers | 36 | 370.0 (294.0-446.0) | 0.745 |
| Non-smokers | 06 | 367.0 (248.7-485.3) | |
| Tobacco habit | |||
| Yes | 08 | 394.0 (352.3-435.6) | 0.022 |
| No | 34 | 314.0 (266.0-362.0) | |
| Plasma VEGF (median) | |||
| <275.2 pg/mL | 21 | 348.0 (246.1-449.9) | 0.885 |
| ≥ 275.2 pg/mL | 21 | 370.0 (288.3-451.7) |
T, tumor; N, nodal status; ECOG, Eastern Cooperative Oncology Group; VEGF, vascular endothelial growth factor; 95% CI, 95% confidence interval.